insights_auto
Nega BOT oshdi 25,00%?
Batafsil oʻrganishchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,010 A$
arrow_upward
+25,00%(+0,0020) 1K
17-noy, 16:10:06 (GMT+11) · AUD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBOT tikeri uchun statistika yaratilmoqda...
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
24,86 mln
Oʻrtacha hajm
10,87 mln
Hajmi
10,30 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Ochish
0,01 A$
Yuqori
0,01 A$
Past
0,01 A$
Bozor kapitali
24,86 mln
Oʻrtacha hajm
10,87 mln
Hajmi
10,30 mln
52 haftalik eng yuqori
0,15 A$
52 haftalik eng past
0,01 A$
Aksiya boʻyicha daromad
-0,03 A$
Muomaladagi aksiyalar
2,76 mlrd
Xodimlar soni
11
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
TradingView
·
1 soat oldin
Dow, S&P 500, Nasdaq Futures Mixed Ahead Of Much-Anticipated Nvidia Earnings, Anthropic IPO: SLS, BABA, JPM, OMER In Focus
ChartMill
·
9 soat oldin
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
The Motley Fool
·
14 soat oldin
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
Traders Union
·
7 soat oldin
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profil
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Botanix Pharmaceuticals Ltd haqida